Tuesday, February 8, 2011

February Newsletter from Asbestos.com

Asbestos.com
FEBRUARY 2011 NEWSLETTER
Asbestos.com Newsletter
Feature Story

Mesothelioma Support Groups Alleviate the Emotional Burden of the Rare Cancer

 

Terminal cancers such as malignant mesothelioma affect far more than the patient's physical health. The patient and his or her loved ones also encounter significant emotional stress. While a doctor can tend to the medical component of mesothelioma treatment, support groups can better address the mental and emotional needs that accompany the physical aspect.

 

According to the psychiatrist Elisabeth Kübler-Ross, M.D., those coming to terms with a terminal diagnosis experience five stages of grief: denial, anger, bargaining, depression and acceptance. 

 

Many mesothelioma patients and their loved ones experience denial when first facing the news of the cancer. Typically, denial is a defense mechanism and is commonly expressed in statements such as, "This is not happening to me" or "My loved one is not really ill."

 

Eventually, denial can no longer offset reality, and anger sets in. Patients often feel angry at God or a higher being for allowing the illness. Meanwhile, family members internalize the anger and blame themselves for their loved one's death or feel angry at the patient for passing away.

 

In the bargaining stage, which replaces anger and typically occurs as the patient is fighting the cancer, individuals attempt to postpone death. Typically, this indicates awareness that death is eminent, yet the grieving individual may bargain with a higher power to prolong the patient's life.

 

Once the mourner recognizes that bargaining will not change the patient's prognosis, depression may set in. Following diagnosis or death of a loved one, many note moderate to severe feelings of hopelessness that may interfere with sleep, appetite, personality traits or interest in daily activities.

 

Acceptance is the final stage in the grief process. After experiencing the former emotions, acceptance signifies peace with the situation. Although arriving at this stage takes time, it is often facilitated through a comforting support network. These emotions are natural and in no way indicative of weakness. Talking to others in similar situations provides reassurance and comfort in knowing they are not alone.

 

Mental health professionals - particularly those who specialize in terminal illnesses - are well equipped to help process these emotions and deal with loss. Local or online-based support groups are also excellent resources for mesothelioma patients and their family and friends. A network of fellow patients, survivors, caregivers and loved ones can provide mesothelioma patients and their families a healthy means of coping with the diagnosis.

 

Mesothelioma presents a unique situation where patients and their families have only a short window to process the situation. The news is often a shock, and those involved tend to feel resentment towards the companies whose asbestos-laced products placed the patient in harm's way. Although the cancer is rare, many groups exist to address the unique needs of mesothelioma patients and their relatives. 

 

Additional information on support groups and coping with a mesothelioma diagnosis may be found through the Mesothelioma Center.

Treatment Breakthroughs

Mesothelioma Treatments Making Headway When Combined in Multimodality Therapy

Although no cure has been discovered for mesothelioma, recent clinical trials and research studies have made great strides. Multimodality therapy, or the combination of multiple treatment options, has begun to show promising results in extending the life expectancy and quality of life for mesothelioma patients.

Mesothelioma Study Illustrates Increased Survival Rates After Multimodal Treatment with Radiotherapy

A recent study exploring the effects of radiotherapy alone or in conjunction with chemotherapy as post-surgical treatment reveals that survival rates, especially in Stage II patients, are improved by a multimodal approach involving radiotherapy.
Mesothelioma Research

Mesothelioma Nutrition Spotlight: Garlic and Cancer

As a key ingredient in a wide range of recipes, garlic is a familiar food in many kitchens, yet the plant's benefits extend far beyond adding flavor to dinner. While stomach and prostate cancer are most receptive to the effects of garlic, all forms of cancer including malignant mesothelioma may display positive results from garlic consumption.

Mesothelioma Immunotherapy Recently Analyzed by Researchers for Its Role in Treatment

Malignant pleural mesothelioma is a rare form of cancer that affects the pleura and commonly comes with a poor prognosis. According to various studies, the number of reported cases of mesothelioma worldwide is expected to rise each year and reach a peak sometime between 2010 and 2020.

Mesothelioma Survival Rates in Pleural Patients are Affected by Asbestos Burden Levels

Many questions have been raised on how much asbestos exposure and asbestos fiber burden in the body relates to the development of mesothelioma. Numerous studies have been conducted to determine the amount of asbestos exposure necessary to develop mesothelioma, often showing promising results.

Mesothelioma Cell Types and Their Effect on Patient Prognosis

Anatomical studies show there are three distinct types of mesothelioma cells, each differentiated by biological structure. Clinical medicine classifies mesothelioma into subsections based upon the type of cell found in the patient's tumors, and research reveals patient prognosis can be affected by the diagnosed cell type.

Mesothelioma Risk Evaluated in Exposure Science Review

Primarily linked to the exposure of asbestos fibers, mesothelioma is a dangerous and aggressive cancer that attacks the lining of the lungs, abdomen and heart, called the mesothelium. Due to the long latency period associated with the disease, cases are expected to rise internationally each year until reaching a peak sometime between 2010 and 2020.
Diagnosis Developments

Mesothelioma Diagnosis in an Early Stage May Positively Impact Prognosis

A typical mesothelioma diagnosis occurs three to six months after the patient's first visit to a doctor to discuss breathing problems or chest and abdominal pain. As with other cancers, early detection can improve the patient's prognosis, yet the uncharacteristically long latency period of mesothelioma can pose difficulties in early identification of the disease.

Mesothelioma Biomarkers May Contribute to Early Diagnostic Screenings

Compounds known as "biomarkers" are produced during cancer development and are often used to measure disease progression. In an attempt to make earlier diagnosis of mesothelioma possible, studies are examining how the presence of certain biomarkers can indicate a tumor's existence and accelerate the diagnostic process.
New Clinical Trials

Mesothelioma Clinical Trials are Making Headway in the Search for a Cure

Mesothelioma is an aggressive form of asbestos-related cancer with an extremely low survival rate. Every year cancer researchers and doctors around the country perform a multitude of clinical trials in an effort to search for a cure to this deadly disease. Any cancer drug or treatment that has been approved for the general public has undergone extensive testing with clinical trials.
Mesothelioma in the Media

Mesothelioma Risk Reduced Through Turkey's Ban of Asbestos

According to a statement released by Turkey's Environment Management Directorate-General, all uses of asbestos were officially banned on Friday, Dec. 31, 2010.

Home | Mesothelioma | Mesothelioma Treatments | Asbestos Cancer  |
Navy Veterans & Mesothelioma |
Asbestos Exposure | Legal Options
In This Issue
Mesothelioma Support Groups
Mesothelioma Research
Diagnosis Developments
Mesothelioma in the Media
Asbestos Awareness Wristbands

This email was sent to florentinaelenescu1@gmail.com by newsletter@asbestos.com |  
Asbestos.com | 20 N. Orange Ave. | Suite 1450 | Orlando | FL | 328o1

No comments:

Post a Comment